See other companies on Welcome to the Jungle
Exscientia
AI-based drug discovery
- 201-500 employees
- Healthcare
- B2B
- Artificial Intelligence
- Science
- Littlemore, Oxford, UK
Jump to section
Company mission
Finding faster and smarter ways to discover new and better drugs is what drives Exscientia. By actively applying AI to precision engineer medicines more rapidly and efficiently, they will enable people to live more healthy and productive lives.
Our take
Exscientia was founded to discover smarter and faster ways of developing better new drugs, helping people to live healthier and more productive lives. Its unique approach combines precision experiment with AI to drive products forwards at a rapid and unprecedented pace.
It is revolutionising the industry through leading the development of pharmatech, combining complex drug discovery and advanced artificial intelligence application. As the first company to have an AI-designed molecule enter clinical trials and the first to automate drug design, it has a unique market advantage over competitors.
Already, Exscientia offers unprecedented productivity in drug production, claiming to be able to cut down the time of finding new drugs to 6 months. With this revolutionary pharmatech approach, it is leading the way in helping save lives through automated drug design.
Moving forward, they plan to invest funding to continue the expansion of proprietary pipeline and end-to-end AI drug discovery capabilities
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Cycle to work
- Wellbeing & Mindfulness Support
- Dental & Optical Benefits
- Work from home opportunities
- Health insurance
Funding (last 2 of 8 rounds)
Dec 2023
$2.3m
GRANT
Jul 2021
$1.5m
GRANT
Total funding: $673m
This company has top investors
People progressing
Chris worked as a Human Resources Business Partner at Nielsen before working in HR at Oxford University for over 4 years. He joinied Exscientia as Head of HR in December 2019, and has served as Vice President of People since January 2021.
Cara spent 5 years at Barrington James, before leaving in April 2021 to join Exscientia in May as Talent Acquisition Manager. He was promoted to Director of Talent Acquisition in April 2021.